QUININE SULFATE 300 MG

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

QUININE SULFATE

Mevcut itibaren:

REKAH PHARMACEUTICAL INDUSTRY LTD, ISRAEL

ATC kodu:

P01BC01

Farmasötik formu:

TABLETS

Kompozisyon:

QUININE SULFATE 300 MG

Uygulama yolu:

PER OS

Reçete türü:

Required

Tarafından üretildi:

REKAH PHARMACEUTICAL INDUSTRY LTD, ISRAEL

Terapötik grubu:

QUININE

Terapötik alanı:

QUININE

Terapötik endikasyonlar:

Antimalarial.

Yetkilendirme tarihi:

2015-02-28

Bilgilendirme broşürü

PATIENT PACKAGE INSERT IN ACCORDANCE WITH
THE PHARMACISTS' REGULATIONS (PREPARATIONS) - 1986
THE DISPENSING OF THIS MEDICINE REQUIRES A DOCTOR'S PRESCRIPTION
READ THIS PACKAGE INSERT CAREFULLY IN ITS ENTIRETY
BEFORE USING THIS MEDICINE
THE FORMAT OF THIS LEAFLET WAS DETERMINED BY THE MINISTRY OF HEALTH
AND ITS CONTENT WAS CHECKED AND APPROVED BY IT IN NOVEMBER 2010
QUININE SULFATE
TABLETS
COMPOSITION:
Each tablet contains: Quinine Sulfate 300 mg
INACTIVE INGREDIENTS: Avicel, Maize Starch, Talc, Magnesium Stearate,
Aerosil,
Sucrose, Gelatin, AC-Di-Sol, Carboxymethyl Cellulose Sodium
THERAPEUTIC GROUP:
Antimalarial.
THERAPEUTIC ACTIVITY:
For treatment of malaria.
WHEN SHOULD THE PREPARATION NOT BE USED?
Do not use this medicine if you have a deficiency of the enzyme G6PD
(sensitivity to fava beans). Do not use this medicine if there is a
known
sensitivity to any of its ingredients, or hypersensitivity to quinine.
Do not take
this medicine if there is a known sensitivity to quinidine or other
antimalarials.
If you suffer from muscle weakness disease (myasthenia gravis).
DO NOT TAKE THIS MEDICINE WITHOUT CONSULTING A DOCTOR BEFORE
STARTING TREATMENT:
If you are pregnant, intend to become pregnant or are breastfeeding.
If you are suffering, or have suffered in the past, from impaired
function of:
the heart and/or vascular system, the eyes - optic nerve inflammation,
the
blood system (thrombocytopenia), if you have ever had blackwater
fever, if
you have hypoglycemia, asthma or ringing in the ears (tinnitus).
WARNINGS:
Use of this medicine may cause blurring of vision.
If you are sensitive to any type of food or medicine, inform your
doctor before
commencing treatment with this medicine.
DRUG INTERACTIONS:
If you are taking another drug concomitantly or if you have just
finished
treatment with another medicine, inform the attending doctor, in order
to prevent hazards or lack of efficacy arising from drug interactions.
This
is especially important for medicines belonging to the following
groups:
anticoagulants (such as w